Review



pneumococcal capsular polysaccharides  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    ATCC pneumococcal capsular polysaccharides
    Pneumococcal Capsular Polysaccharides, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pneumococcal+capsular+polysaccharides+type+3/Pneumococcal+Polysaccharide+Powder+Type+3/pmc07436327-30-0-11
    Average 90 stars, based on 6 article reviews
    pneumococcal capsular polysaccharides - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Immune cell activation and cytokine release after stimulation of whole blood with pneumococcal C-polysaccharide and capsular polysaccharides.
    Article Snippet: Pneumococcal capsular polysaccharides type 3, type 9 (9N) and type 23 (23F), (randomly chosen) were purchased from ATCC, (American Type Culture Collection, USA).



    Similar Products

    pneumococcal capsular polysaccharides  (ATCC)
    90
    ATCC pneumococcal capsular polysaccharides
    Pneumococcal Capsular Polysaccharides, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pneumococcal+capsular+polysaccharides+type+3/Pneumococcal+Polysaccharide+Powder+Type+3/pmc07436327-30-0-11
    Average 90 stars, based on 1 article reviews
    pneumococcal capsular polysaccharides - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    pneumococcal capsular polysaccharides type 3  (ATCC)
    90
    ATCC pneumococcal capsular polysaccharides type 3
    Pneumococcal Capsular Polysaccharides Type 3, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pneumococcal+capsular+polysaccharides+type+3/Pneumococcal+Polysaccharide+Powder+Type+3/pm27436768-56-0-17
    Average 90 stars, based on 1 article reviews
    pneumococcal capsular polysaccharides type 3 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    capsular polysaccharides  (ATCC)
    90
    ATCC capsular polysaccharides
    IgG responses to vaccination with PPSs (left panels) and PPS-protein conjugates (right panels) in control and splenectomized rats. Control rats (filled symbols) and splenectomized rats (open symbols) were vaccinated i.v. and s.c. at days 0 and 28 either with 2.5 μg of each of PPS serotypes 4, 6B, 9V, 14, 19F, and 23F or with a tetravalent, PCV consisting of <t>polysaccharides</t> of pneumococcal serotypes 6B, 14, 19F, and 23F conjugated to tetanus toxoid. Left panels show IgG responses at days 0, 5, 28, 33, and 56 after vaccination with PPS. Antibody responses to serotypes 4 and 9V are not shown but displayed a course similar to that for serotype 6B. Right panels show IgG responses at days 0, 5, 28, 33, and 56 after vaccination with PCV. Antibody titers are expressed in units per milliliter. Shown are geometric mean antibody titers and standard errors of the means.
    Capsular Polysaccharides, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pneumococcal+capsular+polysaccharides+type+3/Pneumococcal+Polysaccharide+Powder+Type+3/pmc00098850-54-10-12
    Average 90 stars, based on 1 article reviews
    capsular polysaccharides - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    IgG responses to vaccination with PPSs (left panels) and PPS-protein conjugates (right panels) in control and splenectomized rats. Control rats (filled symbols) and splenectomized rats (open symbols) were vaccinated i.v. and s.c. at days 0 and 28 either with 2.5 μg of each of PPS serotypes 4, 6B, 9V, 14, 19F, and 23F or with a tetravalent, PCV consisting of polysaccharides of pneumococcal serotypes 6B, 14, 19F, and 23F conjugated to tetanus toxoid. Left panels show IgG responses at days 0, 5, 28, 33, and 56 after vaccination with PPS. Antibody responses to serotypes 4 and 9V are not shown but displayed a course similar to that for serotype 6B. Right panels show IgG responses at days 0, 5, 28, 33, and 56 after vaccination with PCV. Antibody titers are expressed in units per milliliter. Shown are geometric mean antibody titers and standard errors of the means.

    Journal:

    Article Title: Pneumococcal Conjugate Vaccines Overcome Splenic Dependency of Antibody Response to Pneumococcal Polysaccharides

    doi: 10.1128/IAI.69.12.7583-7587.2001

    Figure Lengend Snippet: IgG responses to vaccination with PPSs (left panels) and PPS-protein conjugates (right panels) in control and splenectomized rats. Control rats (filled symbols) and splenectomized rats (open symbols) were vaccinated i.v. and s.c. at days 0 and 28 either with 2.5 μg of each of PPS serotypes 4, 6B, 9V, 14, 19F, and 23F or with a tetravalent, PCV consisting of polysaccharides of pneumococcal serotypes 6B, 14, 19F, and 23F conjugated to tetanus toxoid. Left panels show IgG responses at days 0, 5, 28, 33, and 56 after vaccination with PPS. Antibody responses to serotypes 4 and 9V are not shown but displayed a course similar to that for serotype 6B. Right panels show IgG responses at days 0, 5, 28, 33, and 56 after vaccination with PCV. Antibody titers are expressed in units per milliliter. Shown are geometric mean antibody titers and standard errors of the means.

    Article Snippet: Microtiter plates (Greiner Labortechnik, Langerthal, Germany) were coated with pneumococcal capsular polysaccharides (ATCC; 10 μg/ml in 0.9% NaCl) and stored overnight at 37°C.

    Techniques: Control

    Antibody response to serotype 4 and 9V polysaccharides mixed with native or conjugated polysaccharides. Control rats (filled symbols) and splenectomized rats (open symbols) were i.v. and s.c. vaccinated on days 0 and 28 with 2.5 μg of the PPS serotypes 4 and 9V mixed with conjugated (broken lines) or native (solid lines) polysaccharides of serotypes 6B, 14, 19F, and 23F. See Fig. ​Fig.11 legend for further details.

    Journal:

    Article Title: Pneumococcal Conjugate Vaccines Overcome Splenic Dependency of Antibody Response to Pneumococcal Polysaccharides

    doi: 10.1128/IAI.69.12.7583-7587.2001

    Figure Lengend Snippet: Antibody response to serotype 4 and 9V polysaccharides mixed with native or conjugated polysaccharides. Control rats (filled symbols) and splenectomized rats (open symbols) were i.v. and s.c. vaccinated on days 0 and 28 with 2.5 μg of the PPS serotypes 4 and 9V mixed with conjugated (broken lines) or native (solid lines) polysaccharides of serotypes 6B, 14, 19F, and 23F. See Fig. ​Fig.11 legend for further details.

    Article Snippet: Microtiter plates (Greiner Labortechnik, Langerthal, Germany) were coated with pneumococcal capsular polysaccharides (ATCC; 10 μg/ml in 0.9% NaCl) and stored overnight at 37°C.

    Techniques: Control